-
-
-
-
-
-
-
La Jolla Pharmaceutical (LJPC) Reports Treatment of First Patient in GIAPREZA (angiotensin II) Pediatric Study
-
-
-
-
-
-
-
SunTrust Is Positive On La Jolla Pharma (LJPC), Raises FY 2017/18 EPS Est., "We Expect LJPC-501 Approval On Positive ATHOS-3"
-
-
-
-
-
-
-
Form S-3/A LA JOLLA PHARMACEUTICAL
-
70,892 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

